The effect of repeated administration of methotrexate (MTX) on rat ovary: measurement of serum antimullerian hormone (AMH) levels

References

• Baarends WM, Uilenbroek JT, Kramer P, Hoogerbrugge JW, van Leeuwen EC, Themmen AP, Grootegoed JA. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 1995;136:4951–4962.
   PubMed Web of Science ®Google Scholar
• Bonilla-Musoles F, Castillo JC, Caballero O, Pérez-Panades J, Bonilla F Jr, Dolz M, Osborne N. Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure. Clin Exp Obstet Gynecol 2012;39:13–18.
   PubMed Web of Science ®Google Scholar
• Visser JA, Schipper I, Laven JS, Themmen AP. Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol 2012;8:331–341.
   PubMed Web of Science ®Google Scholar
• Gilchrist RB, Ritter LJ, Armstrong DT. Oocyte-somatic cell interactions during follicle development in mammals. Anim Reprod Sci 2004;82-83:431–446.
   PubMed Web of Science ®Google Scholar
• Carbone PP. The role of chemotherapy in the treatment of cancer of the breast. Am J Clin Pathol 1975;64:774–779.
   PubMedGoogle Scholar
• Furst DE. The rational use of methotrexate in rheumatoid arthritis and other rheumatic diseases. Br J Rheumatol 1997;36:1196–1204.
   PubMedGoogle Scholar
• Widemann BC, Adamson PC. Understanding and managing methotrexate nephrotoxicity. Oncologist 2006;11:694–703.
   PubMed Web of Science ®Google Scholar
• Kamen BA, Moulder JE, Kun LE, Ring BJ, Adams SM, Fish BL, Holcenberg JS. Effects of single-dose and fractionated cranial irradiation on rat brain accumulation of methotrexate. Cancer Res 1984;44:5092–5094.
   PubMedGoogle Scholar
• Vezmar S, Becker A, Bode U, Jaehde U. Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy 2003;49:92–104.
   PubMed Web of Science ®Google Scholar
• Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology 1999;140:5789–5796.
   PubMed Web of Science ®Google Scholar
• Gigli I, Cushman RA, Wahl CM, Fortune JE. Evidence for a role for anti-Mullerian hormone in the suppression of follicle activation in mouse ovaries and bovine ovarian cortex grafted beneath the chick chorioallantoic membrane. Mol Reprod Dev 2005;71:480–488.
   PubMedGoogle Scholar
• Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, et al. Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 2001;142:4891–4899.
   PubMed Web of Science ®Google Scholar
• Meirow D, Biederman H, Anderson RA, Wallace WH. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol 2010;53:727–739.
   PubMed Web of Science ®Google Scholar
• Chang HJ, Han SH, Lee JR, Jee BC, Lee BI, Suh CS, Kim SH. Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Müllerian hormone levels. Fertil Steril 2010;94:343–349.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Themmen AP, Al-Qahtani A, Groome NP, Cameron DA. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod 2006;21:2583–2592.
   PubMed Web of Science ®Google Scholar
• Decanter C, Morschhauser F, Pigny P, Lefebvre C, Gallo C, Dewailly D. Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results. Reprod Biomed Online 2010;20:280–285.
   PubMed Web of Science ®Google Scholar
• Rosendahl M, Andersen CY, Ernst E, Westergaard LG, Rasmussen PE, Loft A, Andersen AN. Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study. Hum Reprod 2008;23:2475–2483.
   PubMed Web of Science ®Google Scholar
• The 54th meeting of the WHO Expert Committee on Biological Standardization. WHO Guidelines on Nonclinical Evaluation of Vaccines; 2003. pp 10.
   Google Scholar
• Gestational Trophoblastic Disease, SOGC Clinical Practice Guidelines, No. 114; 2002.
   Google Scholar
• Yeh J, Kim BS, Liang YJ, Peresie J. Gonadotropin stimulation as a challenge to calibrate cisplatin induced ovarian damage in the female rat. Reprod Toxicol 2009;28:556–562.
   PubMed Web of Science ®Google Scholar
• Gracia CR, Sammel MD, Freeman E, Prewitt M, Carlson C, Ray A, Vance A, Ginsberg JP. Impact of cancer therapies on ovarian reserve. Fertil Steril 2012;97:134–40.e1.
   PubMed Web of Science ®Google Scholar
• Sahambi SK, Visser JA, Themmen AP, Mayer LP, Devine PJ. Correlation of serum anti-Müllerian hormone with accelerated follicle loss following 4-vinylcyclohexene diepoxide-induced follicle loss in mice. Reprod Toxicol 2008;26:116–122.
   PubMedGoogle Scholar
• Shamberger RC, Rosenberg SA, Seipp CA, Sherins RJ. Effects of high-dose methotrexate and vincristine on ovarian and testicular functions in patients undergoing postoperative adjuvant treatment of osteosarcoma. Cancer Treat Rep 1981;65:739–746.
   PubMedGoogle Scholar
• Gol M, Saygili U, Koyuncuoglu M, Uslu T. Influence of high-dose methotrexate therapy on the primordial follicles of the mouse ovary. J Obstet Gynaecol Res 2009;35:429–433.
   PubMed Web of Science ®Google Scholar
• Oriol B, Barrio A, Pacheco A, Serna J, Zuzuarregui JL, Garcia-Velasco JA. Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve. Fertil Steril 2008;90:1579–1582.
   PubMed Web of Science ®Google Scholar